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Abstract Tuberculosis (TB) is a major global health
threat caused by Mycobacterium tuberculosis (Mtb). It is
further fueled by the HIV pandemic and by increasing
incidences of multidrug resistant Mtb-strains. Rv2827c, a
hypothetical protein from Mtb, has been implicated in the
survival of Mtb in the macrophages of the host. The three-
dimensional structure of Rv2827c has been determined by
the three-wavelength anomalous diffraction technique
using bromide-derivatized crystals and reﬁned to a reso-
lution of 1.93 A ˚. The asymmetric unit of the orthorhombic
crystals contains two independent protein molecules
related by a non-crystallographic translation. The tertiary
structure of Rv2827c comprises two domains: an
N-terminal domain displaying a winged helix topology and
a C-terminal domain, which appears to constitute a new
and unique fold. Based on structural homology consider-
ations and additional biochemical evidence, it could be
established that Rv2827c is a DNA-binding protein. Once
the understanding of the structure-function relationship of
Rv2827c extends to the function of Rv2827c in vivo, new
clues for the rational design of novel intervention strategies
may be obtained.
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Introduction
Globally, tuberculosis (TB) represents a major health
threat with 9 million cases and close to 2 million deaths
annually [80]. Although drugs to treat TB are available,
the complex and long-lasting treatment scheme with three
to four drugs over a period of 6–9 months leads to poor
patient compliance. In several regions, notably in sub-
Saharan Africa, the re-emergence of TB was further
fueled by the pandemic with human immunodeﬁciency
virus (HIV) responsible for acquired immunodeﬁciency
syndrome (AIDS) [40]. As a corollary, incidences of
multidrug-resistant (MDR) and even extensively drug-
resistant (XDR)-TB have increased profoundly. MDR-TB
is resistant to treatment with ﬁrst-line drugs, whereas
XDR-TB is virtually untreatable with the currently
available drugs. Drug development for TB has been lar-
gely neglected in the last decades and hence appropriate
intervention methods to efﬁciently combat the re-emer-
gent threat of TB are urgently required. The etiologic
agent of TB, Mycobacterium tuberculosis (Mtb), is a
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After adequate activation by cytokines, notably inter-
feron-gamma (IFN-c), macrophages acquire increased
antibacterial capacities. These activated macrophages can
control Mtb growth though they fail to achieve sterile
eradication [84]. Consequently, gene products essential
for Mtb growth or persistence in resting or activated
macrophages, respectively, represent potential targets for
novel drugs.
Genome-wide expression proﬁling of microbial patho-
gens has become a useful tool to identify single genes and
gene networks that are differentially expressed under
different conditions. In numerous cases, these analyses
have provided clues to gene functions and persistence.
Among the close to 4,000 genes encoded by the H37Rv
strain of Mtb [15, 21], a group of proteins has been
identiﬁed in microarray experiments as being differen-
tially expressed and therefore considered potentially
important for persistence and pathogenicity of Mtb [66,
67]. Currently, only limited information on the three-
dimensional (3-D) architecture and the structural features
of these proteins is available. It is well conceivable that
the understanding of the 3-D structures of these proteins
will provide a valuable basis for a better understanding of
pathogenesis and persistence of Mtb and for structure-
based design of novel intervention strategies against
tuberculosis.
Based on its amino acid sequence, Rv2827c has been
annotated as a hypothetical protein with unknown function
[21]. The protein is composed of 295 amino acid residues
with a molecular weight of 32.3 kDa and an isoelectric
point of 9.3. According to Sassetti et al. [70] and
Lamichhane et al. [44], this protein is critical for Mtb
replication. Mtb mutants lacking a functional copy of the
rv2827c gene fail to grow in vitro. The protein Rv2827c is
approximately threefold upregulated upon infection of
macrophages with Mtb in comparison to in vitro grown
cultures of Mtb [66, 67]. IFN-c activation of macrophages
leads to a further threefold increase as compared to the
situation in resting macrophages. Based on these observa-
tions we proposed that Rv2827c plays a critical role in Mtb
survival in macrophages and hence represents a potential
target for future intervention strategies.
The crystallization and preliminary diffraction experi-
ments for Rv2827c have recently been reported [38].
Here, we describe the X-ray structure of Rv2827c, solved
by the MAD method [36] utilizing bromide-derivatized
crystals [23]. The structure of Rv2827c and its potential
function as a DNA binding protein will be described and
discussed in detail. The elucidation of the structure—
function relationship for Rv2827c may provide a blue-
print for the rational design of a drug candidate targeted
at this molecule.
Materials and methods
Cloning, expression, puriﬁcation and crystallization
The cloning, expression, puriﬁcation, crystallization and
preliminary X-ray diffraction experiments for the native
crystals of Rv2827c have been described previously [38].
Brieﬂy: recombinant, full-length Rv2827c, with three
additional N-terminal residues (Gly-2, Ala-1 and Met0)
introduced for cloning purposes, was crystallized from 2 M
sodium formate and 100 mM sodium acetate (pH 4.7)
supplemented with the 3-(1-pyridino)-1-propane sulfonate
(aka non-detergent sulfo-betaine 201) or 6-aminocaproic
acid at 277 K. Single crystals grew out of the surface of
spherulites within several weeks. The crystals are ortho-
rhombic, space group P21212 with unit-cell parameters
a = 87.42 A ˚, b = 180.65 A ˚ and c = 35.11 A ˚ and diffract
X-rays to a resolution of better than 2.0 A ˚.
Data collection and processing
Due to the lack of a suitable search model for molecular
replacement, three-wavelength MAD data were collected
from a crystal soaked with 0.3 M NaBr (in crystallization
buffer) for 2 days and additionally for 20 min in 0.5 M
NaBr (in crystallization buffer) immediately before the
X-ray experiment. A crystal with dimensions 200 9 150 9
150 lm was mounted in a nylon ﬁber loop, cryo-protected
for 10 s in reservoir solution containing 15% (v/v) MPD
and 0.5 M NaBr and ﬂash-cooled to 100 K in a nitrogen
gas stream. Diffraction data were then collected on the
EMBL beamline BW7A (DESY, Hamburg, Germany)
using a MARCCD detector. For all three wavelengths, 360 
of data were collected to 2.6 A ˚ resolution (Table 1). Data
were indexed and integrated using DENZO [59] and scaled
using SCALEPACK [59]. The redundancy-independent
merging R-factor Rr.i.m. as well as the precision-indicating
merging R-factor Rp.i.m. [79] were calculated using the
program RMERGE (available from http://www.embl-
hamburg.de/*msweiss/projects/msw_qual.html or from
MSW upon request). Intensities were converted to struc-
ture-factor amplitudes using the program TRUNCATE [17,
26] and the optical resolution was calculated using the
program SFCHECK [78].
Structure determination and reﬁnement
The structure of Rv2827c was solved using the three-
wavelength MAD protocol of Auto-Rickshaw, the EMBL-
Hamburg automated crystal structure determination plat-
form [63]. The input diffraction data were uploaded to the
Auto-Rickshaw server and then prepared and converted for
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[17]. FA values were calculated using the program
SHELXC [74]. Based on an initial analysis of the data, the
maximum resolution for substructure determination and
initial phase calculation was set to 3.4 A ˚. Twenty-three
bromide positions were located with the program SHELXD
[71]. The correct hand for the substructure was determined
using the programs ABS [34] and SHELXE [73]. The
occupancy of all substructure atoms was reﬁned using the
program MLPHARE [17]. The initial phases were
improved using density modiﬁcation and phase extension
to 2.60 A ˚ resolution using the program DM [22].
Approximately 50% of the model was built automatically
using the program ARP/wARP [52, 65]. The missing parts
of the model were then added by assembling the interme-
diate models generated from ARP/wARP. As soon as the
model was 80% complete, reﬁnement was continued
against the 1.93 A ˚ resolution native dataset. Reﬁnement
was performed in REFMAC5 [54] using the maximum
likelihood target function including TLS parameters [82].
For TLS reﬁnement, four TLS groups were used per pro-
tein chain (Gly-2-Ile80, Pro83-Asp94, Gly98-Thr253 and
Val255-Gly293). In between reﬁnement cycles, the struc-
ture was rebuilt manually in COOT [24]. The ﬁnal model is
characterized by R and Rfree factors of 18.3% and 22.4%,
respectively (Table 2). Structural superpositions and sear-
ches were carried out using the program ALIGN [20] and
the SSM server (http://www.ebi.ac.uk/msd-srv/ssm,[ 42]).
Electrostatic potential analysis was performed using the
GRASP [55] and PYMOL (www.pymol.org) programs.
The stereochemistry of the ﬁnal model was analyzed using
PROCHECK [45]. The reﬁned structure and corresponding
structure-factor amplitudes have been deposited with the
PDB under the accession code 1ZEL.
Table 1 Data collection and processing statistics
Number of crystals 1 1
Beamline X13 BW7A
Wavelength [A ˚] 0.8031 0.9195 (peak) 0.9203 (inﬂection) 0.9095 (remote)
Temperature [K] 100 100
Crystal-to-detector distance [mm] 180 210
Rotation range per image [ ] 1.0 1.0
Total rotation range [ ] 156 360
Space group P21212 P21212
Unit cell parameters [A ˚] a = 87.42 a = 87.48 a = 87.47 a = 88.58
b = 180.65 b = 180.79 b = 180.69 b = 182.95
c = 35.11 c = 35.43 c = 35.39 c = 35.82
Mosaicity [ ] 0.60 1.00 1.00 0.95
Resolution limits [A ˚] 50.0–1.93 99–2.60
(2.00–1.93) (2.69–2.60)
Total number of reﬂections 268,981 257,694 257,209 258,683
Unique reﬂections 43,027 18,227 18,143 18,166
Redundancy 6.3 14.1 14.2 14.2
I/r(I) 23.3 (3.7) 30.3 (5.8) 32.8 (6.9) 27.9 (5.7)
Completeness [%] 99.9 (99.8) 99.9 (99.2) 99.9 (99.7) 99.9 (100.0)
Rmerge [%]
a 7.6 (49.8) 10.2 (64.6) 9.2 (55.8) 10.8 (63.0)
Rr.i.m. [%]
b 8.3 (54.8) 10.7 (76.7) 9.4 (59.5) 11.3 (66.8)
Rp.i.m. [%]
c 3.3 (22.5) 2.8 (20.8) 2.5 (16.2) 3.0 (17.6)
Ranom [%]
d – 3.2 (16.2) 2.2 (13.3) 3.3 (15.5)
Overall B factor from Wilson plot [A ˚ b] 24.2 41.9 47.1 48.8
Optical resolution [A ˚] 1.55 1.88 1.89 1.91
Values in parentheses correspond to the highest resolution shell
a Rmerge = RhklRi|Ii(hkl) - hI(hkl)i|/RhklRiIi(hkl), where Ii(hkl) is the intensity of the observation i of the reﬂection hkl
b Rr.i.m = Rhkl(N/(N - 1))
1/2Ri|Ii(hkl) - hI(hkl)i|/RhklRiIi(hkl), where Ii(hkl) is the intensity of the observation i of the reﬂection hkl and N is the
redundancy
c Rp.i.m = Rhkl(1/(N - 1))
1/2Ri|Ii(hkl) - hI(hkl)i|/RhklRiIi(hkl), where Ii(hkl) is the intensity of the observation i of the reﬂection hkl and N is the
redundancy
d Ranom = Rhkl|I(hkl) - I(-h-k-l)|/RhklhI(hkl)i, where I(hkl) and I(-h-k-l) are the intensities of the reﬂections hkl and -h-k-l, respectively
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For the deﬁnition of domains in the 3-D structure of
Rv2827c, various approaches were used. First, the structure
was analyzed using the program 123D? (http://123d.
ncifcrf.gov/123D?.html,[ 1]), which combines sequence
proﬁles, secondary structure prediction, and contact
capacity potentials to thread a protein sequence through the
set of structures. Secondly, the vector alignment search tool
VAST Search [31, 48] was employed using services of the
National Center for Biotechnology Information (NCBI,
http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.shtml).
VAST deﬁnes domains based on structure similarity sear-
ches. Thirdly, automatic domain deﬁnition was attempted
by analyzing accessible surface areas (ASA) on a residue
by residue basis. A high value of ASA ([100 A ˚ 2) for a few
adjacent residues indicates that a particular sequence
fragment is well exposed and may thus constitute a linker
or a hinge between domains. This calculation was carried
out using the PISA server [43]. A further attempt on
domain deﬁnition was made using a normal mode calcu-
lation [76] using the elNemo server (http://www.igs.cnrs-
mrs.fr/elnemo/index.html). Finally, a TLS group analysis
was performed using the TLS Motion Determination
server (TLSMD, http://skuld.bmsc.washington.edu/*tlsmd/,
[60, 61]). For this analysis, the protein was divided into two
to six TLS groups.
Initial DNA binding test
Without any information about the potential DNA
sequence being recognized by Rv2827c, initial DNA
binding tests were performed with four dsDNA fragments
(Table 3), taken from the structures of various DNA
binding proteins containing a wHTH motif: 50-GGTTCTA
GAACC-30 (PDB code 3HTS, [46]), 50-CTATGTAGTCTG
TTG-30 (PDB code 1RH6, [69]), 50-AAAAAGGGGAAGT
GGG-30 (PDB code 1PUE, [41]), and 50-GAGAAGTGAA
AGTACTTTCACTTCTC-30 (PDB code 1IF1, [25]). The
oligonucleotides were obtained from MWG Biotech and
dissolved in a buffer composed of 10 mM Tris pH 8.5,
50 mM NaCl, 1 mM EDTA. In order to obtain a double
stranded form, the palindromic fragments 50-GGTTCTA
GAACC-30 and 50-GAGAAGTGAAAGTACTTTCACTT
CTC-30 were annealed at 95 C for 10 min and left for slow
cooling. The other two fragments 50-CTATGTAGTCTG
TTG-30 and 50-AAAAAGGGGAAGTGGG-30 were mixed
with their complementary fragments 50-CAACAGACTAC
ATAG-30 and 50-CCCACTTCCCCTTTTT-30, respectively
and prior to annealing them as described above. Equimolar
amounts of Rv2827c (in 50 mM Tris pH 7.3, 150 mM KCl,
350 mM imidazole, 2 mM DTT) and the corresponding
dsDNA fragments were mixed and dialyzed overnight
against a buffer composed of 50 mM Tris (pH 7.3),
150 mM KCl and 2 mM DTT to slowly remove the
imidazole present in the protein sample [38].
PCR-assisted binding site selection method
The polymerase chain reaction (PCR) assisted binding site
selection method used here was described earlier by Nørby
et al. [56]. The following ssDNA fragment was designed
and obtained from MWG Biotech: 50-CAATCCATGGCG
ACTCTGCATCCGC(N)30GTGTCACCGGCATGACTCG
AGACCA-30. It contains 30 nucleotides with a random
sequence ﬂanked on both sides by a 25-base long con-
served fragment with recognition sites for NcoI and XhoIa t
the 50 and 30 ends, respectively. The recognition sites
(underlined) were necessary for subcloning purposes.
Table 2 Reﬁnement statistics
PDB code 1ZEL
Resolution limits [A ˚] 30.0 –1.93
Data cutoff [F/r(F)] 0.0
Completeness [%] 99.9
Total No. of reﬂections 41,592
No. of reﬂections in working set 40,251
No. of reﬂections in test set 1,341
R [%]
a 18.3
Rfree [%]
b 22.4
No. of amino acid residues 588
No. of protein atoms 4,620
No. of sodium ions 2
No. of acetate atoms 8
No. of MPD atoms 8
No. of formate atoms 45
No. of solvent atoms 340
R.m.s.d. bond lengths [A ˚] 0.012
R.m.s.d. bond angles [8] 1.38
Ramachandran plot [%]: most favored/additionally
allowed region
92/8
a R = Rhkl|| Fo| - |Fc|| / Rhkl|Fo| for all reﬂections, where Fo and Fc
are observed and calculated structure factors, respectively
b Rfree was calculated against 3.2% (1,341) of all reﬂections, ran-
domly excluded from the reﬁnement
Table 3 DNA sequences tested for DNA binding
DNA sequence 50–30 G ? C [%] Stabilizing
GGTTCTAGAACC 50 Y
CTATGTAGTCTGTTG 40 Y
AAAAAGGGGAAGTGGG 50 Y
GAGAAGTGAAAGTACTTTCACTTCTC 38 N
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30 (forward) containing a recognition site for NcoI, and
50-TGGTCTCGAGTCATGCCGGTGACAC-30 (reverse)
with an XhoI recognition site were designed for PCR
ampliﬁcation. The ssDNA fragment was converted to
dsDNA by means of DNA polymerase I Klenow fragment
and the reverse primer. For the protein-DNA binding test,
2 ll of 10 mg/ml Rv2827c were spotted onto 1 cm
2 of
nitrocellulose membrane and air dried. The ﬁlter was
blocked by washing it for 30 min at 4 C in a buffer com-
posed of 50 mM Tris pH 7.3, 40 mM KCl, 3 mM MgCl2,
2 mM DTT and 0.5% (w/v) carnation milk. The membrane
was exposed overnight at 4 Ct o2 0 0ll of the binding
buffer (50 mM Tris pH 7.3, 40 mM KCl, 3 mM MgCl2,
2 mM DTT) supplemented with 10 pmol of the random
dsDNA described above. Afterwards, the membrane was
extensively washed in binding buffer ﬁrst with 0.5% (w/v)
carnation milk and then without. As a control, the mem-
brane without Rv2827c was exposed to the mixture of
random dsDNA. To dissociate DNA bound to the protein
(and to the membrane in the control experiment), the
membrane was washed in 0.5 M KCl and to check for the
presence of DNA in the eluted samples and to amplify it,
PCR was performed using the primers described above.
Four different samples were investigated: (1) the eluent
from the control membrane washed in washing (low salt)
buffer and (2) in 0.5 M KCl, (3) the eluent from the
membrane with immobilized Rv2827c washed in low salt
buffer (as additional control) and (4) in 0.5 M KCl. The
latter sample (4) was then used for the next round of the
experiment. The whole procedure was repeated seven
times. After each cycle of binding, PCR was performed to
analyze the quality and quantity of binding. After the ﬁnal
cycle, the ampliﬁed DNA fragments were digested with
NcoI and XhoI and subcloned into the corresponding sites
of pETM-11 vector containing a kanamycine resistance.
TOP10 cells (Invitrogen) were transformed with the
recombinant plasmid. The presence of the inserted DNA
fragment was veriﬁed by PCR. Seventeen randomly
selected clones were sent for oligonucleotide sequencing
(Table 4).
Modeling the complex of Rv2827c with dsDNA
In order to construct a model of the Rv2827c/DNA-com-
plex, the N-terminal domain of Rv2827c was superimposed
onto the winged helix domain of the interferon regulatory
factor 3 (IRF-3, PDB code 1T2 K, [64]) complexed with a
31-mer DNA fragment. Then, the C-terminal domain
(residues Pro83-Ala295) was manually rotated and trans-
lated toward the DNA using the molecular graphics
program COOT [24]. By repeating this operation with
C-terminal fragment Asp94-Ala295 the ﬁt of Rv2827c onto
the DNA can be markedly improved. Further minor
adjustments in the loop between Leu125 and Val139 fol-
lowed by geometry idealisation resulted in the ﬁnal model.
Results and discussion
Analysis of the primary structure of Rv2827c
A sequence similarity search using the programs BLAST
and PSI-BLAST [2] provided only limited information
Table 4 DNA sequences identiﬁed by PCR-assisted binding site
selection method
DNA sequence [50–30]G ? C [%]
CCCCTGCAACGGCGCACACCAACACACATC 63
TCTAGGACATATTGTTTAAACGCCAGCACC 43
TGCGTTTATGTGTTTCTTGGGGTTGGCAGG 50
GCACGCCACACTCACCATGCAGGACAACCT 60
ATATCGCAGATGACTGATTACCACCCTTCA 43
TTTGAAAAAAGGGAGATGCATAATCATTAT 27
AGTTCACACATTGCAGTTATGGCTGGTGGG 50
ATCCCAGGCATGACGGTTGGCTCTGACCCA 60
GCCGATTGCTTTTTCTTATTAGGGGGGCTA 47
AGAAACAGAATGAGAAGGTCGCACAGCACC 50
CCATTCGCAGATATGAGAAAAAGAGCGAGT 43
CGGCATAACACATAGAGACCGTACACCCTT 50
CTTACCCCCGACCATATTGTTCTACCCCCC 57
TGGGCTAGCCTGGTAGCGCTCTGTTGATTT 53
TAGCTGTTTGTGTTCGCTCGCGTGTTTGTA 47
AAAACCAGGGGAAGTGAAAAGAAACACCCT 43
GAAACAACCACGTCTAAGTCAGCCATCCCC 53
Complementary DNA [50–30]
GATGTGTGTTGGTGTGCGCCGTTGCAGGGG 63
GGTGCTGGCGTTTAAACAATATGTCCTAGA 43
CCTGCCAACCCCAAGAAACACATAAACGCA 50
AGGTTGTCCTGCATGGTGAGTGTGGCGTGC 60
TGAAGGGTGGTAATCAGTCATCTGCGATAT 43
ATAATGATTATGCATCTCCCTTTTTTCAAA 27
CCCACCAGCCATAACTGCAATGTGTGAACT 50
TGGGTCAGAGCCAACCGTCATGCCTGGGAT 60
TAGCCCCCCTAATAAGAAAAAGCAATCGGC 47
GGTGCTGTGCGACCTTCTCATTCTGTTTCT 50
ACTCGCTCTTTTTCTCATATCTGCGAATGG 43
AAGGGTGTACGGTCTCTATGTGTTATGCCG 50
GGGGGGTAGAACAATATGGTCGGGGGTAAG 57
AAATCAACAGAGCGCTACCAGGCTAGCCCA 53
TACAAACACGCGAGCGAACACAAACAGCTA 47
AGGGTGTTTCTTTTCACTTCCCCTGGTTTT 43
GGGGATGGCTGACTTAGACGTGGTTGTTTC 53
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exception is the hypothetical protein Mb2851c from
M. bovis [29] with 100% sequence identity to Rv2827c.
Further hits, albeit at a much lower conﬁdence level,
include phosphoribosylaminoimidazole carboxylase from
Azospirillum brasilense [16] (EMBL/GenBank/DDBJ
databases), with 26% identity and 53% similarity for a 255
amino acid overlap, a hypothetical protein from Pseudo-
monas sp. WBC-3 [47] with 28% identity and 50%
similarity in a 264 aa overlap and the hypothetical protein
SCO15 from Streptomyces coelicolor [6] with 29% iden-
tity and 46% similarity in a 256 aa overlap. Searches with
shorter sequence fragments revealed that the ﬁrst 133
amino acids of Rv2827c exhibit 25% identity and 38%
similarity to seryl-tRNA synthetase from Methanopy-
rus kandleri [75]. The short fragment Asp133-Leu184
displays some evidence for a leucine-zipper motif (LX6)4
and shares 52% identity and 69% similarity with the
putative integral membrane protein from S. avermitilis
[57]. The sequence region Ala172-Glu254 appears to be
homologous to a putative serine/threonine protein kinase
from S. coelicolor [6] with 34% identity and 45% simi-
larity. Rv2827c has not been associated with any
superfamily in the COG [77] or Pfam databases [4]. The
only information about its potential function comes from
the function prediction program ProKnow [62], which
predicts that Rv2827c may have ATP binding activity or
may participate in pantothenate biosynthesis as well as
protein amino acid phosphorylation. However, the evi-
dence ranks [62], are low and comparable for all three
functions. Therefore, the predicted information is not really
reliable. To date, no tertiary structure has been reported to
the Protein Data Bank (PDB) [7] for any protein similar to
Rv2827c. The highest score from sequence-based search
against the PDB identiﬁes 6-hydroxymethyl-7,8-dihydrop-
terin pyrophosphokinase from Escherichia coli (PDB code:
1RU1, [8]) with 29% identity for the 120-residue long
fragment between Leu175 and the C-terminus of Rv2827c
as a potential homologue.
Quality of the structure
The ﬁnal reﬁned model of Rv2827c consists of amino acids
Ala-1 to Ala295 in chain A and Gly-2 to Ala295 in chain B
with the exception of the solvent-exposed loop Arg267-
Arg269 in both chains. It also includes 340 water mole-
cules, two sodium ions, one MPD molecule, 15 formate
ions and two acetate ions. Based on the reﬁnement statis-
tics and stereochemical parameters (Table 2) the quality of
the model is high. About 92% of all residues are in the core
region of the Ramachandran plot and no residues appeared
in the generously allowed or unfavorable area. The root-
mean-square deviation (r.m.s.d.) value between the two
independent molecules in the asymmetric unit is 0.32 A ˚ for
276 pairs of superimposed Ca atoms, which is not signif-
icantly higher than the overall coordinate error of the
structure.
The overall fold of Rv2827c and its topology
The protein structure consists of 15 a-helices and 12
b-strands and belongs to the class 3, a/b family according
to the CATH protein structure classiﬁcation [58] (Fig. 1a,
b). The N-terminal part starts with a short b-strand (b1)
composed of Ala-1-Ser3. Even though the residues Ala-1
and Met0 are a cloning artifact (together with Gly-2 which
is visible only in chain B), it can be expected that in the
native protein, which starts with Val1, the structure is the
same, albeit shorter by three amino acids. Three main
Fig. 1 The three-dimensional structure of Rv2827c from M. tuber-
culosis: a Ribbon representation of Rv2827c. b Topology diagram.
Color codes for A and B: b-sheet, green; a-helices, magenta
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123chain–main chain hydrogen bonds connect the fragment
Val1-Ser3 to strand b5 (Ala78-Ser81) in an antiparallel
fashion. The residues Ala-1 and Met0 strengthen this
antiparallel b-sheet with an additional main chain–main
chain hydrogen bond which connects Ala-1 to Asp82
located at the C-terminus of the strand b5. After leaving the
ﬁrst b-strand, the polypeptide chain continues as a loop and
then enters the three-helix bundle, which is built up of
helices a1 (Ala15-Arg26), a2 (Lys32-Ala42) and a3
(Pro48-Ile58). Helices a2 and a3 form a helix-turn-helix
motif followed by a b-hairpin consisting of the strands b3
(Leu61-Leu64) and b4 (Thr69-Ile73), which, together with
the short strand b2 (Val29-Thr31) form a three-stranded
antiparallel b-sheet. Following another loop is the short
strand b5 (Ala78-Ser81), which interacts with b1i na n
antiparallel fashion. The entire fragment between a1 and
b4 exhibits the canonical winged helix (WH) fold making
Rv2827c a member of the WH or the winged helix-turn-
helix (wHTH) family. The canonical WH motif consists of
two wings (W1 and W2) which are extended loop struc-
tures, three a helices (H1, H2, and H3) and three b-strands
(S1, S2, and S3), arranged in the order H1-S1-H2-H3-S2-
W1-S3-W2 [19, 68]. In Rv2827c, the order is as follows:
a1-b2-a2-a3-b3-W1-b4-W2 where W1 and W2 corre-
spond to the fragments Pro65-Gly68 and Pro74-Glu77,
respectively.
Residues Tyr84-Asp94 form the helical fragment a4
occurring between the N- and C-terminal parts of Rv2827c.
Helix a4 leads to a four-stranded mixed b-sheet exhibiting
the topology b9-b6-b7-b8. Further a-helical fragments
occur in the loops connecting the b-strands: Helix a5
(Gly103-Leu110) between strands b6 (Met100-Ala102)
and b7 (Ile121-Leu125), helix a6 (Asp133-Ser137)
between b7 and b8 (Val139-Val142), and the two helices
a7 (Asp150-Leu154) and a8 (Arg157-Arg164) before
strand b9 (Pro176-Leu178). After leaving the b-sheet, the
protein chain enters the a-helical region composed of
helices a9 (Gly179-Arg190), a10 (Pro196-Val201) and a11
(His203-Asp210). These three helices are arranged in a
circular structure separating the b-sheet and the three-helix
bundle consisting of the almost parallel helices a12
(Ser212-Ser221), a13 (Pro224-Gly238), and a14 (Glu240-
Ala249). The last part of Rv2827c structure consists of the
three-stranded mixed b-sheet with the topology b10-b12-
b11, which comprises the sequence segments Val258-
Thr262, Gln279-Glu283 and Ser272-Ala275, respectively.
The polypeptide chain is terminated with the helical seg-
ment a15 (Leu284-Ala295) that points into the solvent.
Division of the structure into domains
The division of the Rv2827c structure into domains turned
out to be somewhat ambiguous (Fig. 2). The program
123D? [1] divides Rv2827c into three domains: Gly-2-
Ala97, Gly98-Leu183 and Leu184-Ala295. While the
predicted border between the ﬁrst two domains appears to
be reasonable, the one between domains 2 and 3 occurs
exactly in the middle of helix a9 (Gly179-Arg190) and it is
buried in the protein core. The vector alignment search tool
VAST Search [31, 48] predicts four domains: Gly-2-Gly98,
Phe99-Ala152, Leu175-Val255 and Met256-Ala295, where
the ﬁrst predicted domain is identical to the one predicted
by the program 123D?. This can be explained that for this
part of the structure many related structures are available.
The fragment Phe99-Ala152 was assigned as the next
domain although it does not show any similarity to any
known 3-D structures. The sequence Leu153-Gly174 was
left out of the domain prediction by VAST and the next
segment Leu175-Val255 was recognized as a separate
domain. The last sequence stretch (Met256-Ala295) was
again recognized as a separate domain. This fragment
corresponds to the three-stranded b-sheet terminated by an
a-helix. The assignment of this stretch to a domain is
probably sensible, since it interacts with the rest of the
molecule mostly by means of hydrophobic contacts. The
difﬁculties of VAST in assigning domains in the C-termi-
nal part of Rv2827c are a consequence of the lack of
structural homologues for this region. This in turn cor-
roborates the notion that the C-terminal part of Rv2827c
constitutes a novel fold. By examining the solvent-acces-
sible surface area (ASA) on a residue-by-residue basis
using the PISA server [43] two potential linker regions
were deﬁned: Arg93-Asn96 and Lys250-Val255, thus
dividing Rv2827c into three domains. The calculation of
the normal modes using the ElNemo server [76] for
Rv2827c divides the structure into two domains: Gly-2 to
Ser81 and Asp82 to Ala295. The deﬁnition of the ﬁrst
domain contradicts to some extent the deﬁnitions of the
programs 123D? and VAST in that it assigns the helical
fragment a4 (Tyr84-Asp94) to the C-terminal domain of
Rv2827c rather than the N-terminal. The segment Tyr84-
Asp94 exhibits strong interactions with both N- and C-
terminal parts of the protein. The residues Tyr84, Leu87
and Trp90 are surrounded by the hydrophobic side chains
of Ala97, Phe99, Leu101, Ile121, Ile123, Leu125, Leu131,
Leu135 and Val139 from the C-terminal part of Rv2827c.
Furthermore, the segment participates in the hydrogen
bonds Tyr84-OH…His109-NE2, Arg88-NH1…Thr173-O
and Arg88-NH2…Thr173-OG1. On the other side of a4,
Leu85 and Ala92 interact with the hydrophobic side chains
of Val1, Ile80, Val28 and Val29 of the N-terminal part,
Ser89-OG forms a hydrogen bond with Val66-N and the
side chains of Arg93 and Glu33 are connected by a salt
bridge. Based on these considerations the segment Tyr84-
Asp94 should probably be considered part of the C-ter-
minal domain rather than the N-terminal. Similarly, the
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Determination (TLSMD, server [60, 61]) deﬁned the bor-
der between the N-terminal domain and the rest of protein
molecule between Ile80-Ser81 and Ser81-Asp82. The
division of the C-terminal part into further TLS groups was
unclear and did not yield any indication about potential
further domain division, similar to the other programs
mentioned above. Rv2827c is therefore most sensibly
divided into two structural domains.
The N-terminal domain of Rv2827c exhibits DNA
binding features
Table 5 shows the top scored structures related to the N-
terminal domain fragment Thr13-Ile73 of Rv2827c iden-
tiﬁed by the secondary structure matching (SSM) server.
Most of these proteins interact with DNA. The structure
superposition shown in Fig. 3 clearly indicates the struc-
tural similarity between the N-terminal domain of Rv2827c
and other proteins belonging to the WH or wHTH family.
To date, many X-ray structures of WH proteins have been
determined. Whereas the ﬁrst structures were those of
eukaryotic proteins, such as the hepatocyte nuclear factor 3
(HNF-3) [19] and histone H5 [68], it was soon recognized
that the WH motif is common to eukaryotes and
prokaryotes [9]. The most prominent feature of the WH
motif is the presence of the two helices H2 (the stabiliza-
tion helix) and H3 (the recognition helix) and the turn
between them, the length of which is variable [27]. In the
majority of WH protein structures H3 is responsible for the
interaction with DNA. One exception to this rule is the
human regulatory factor X1 where the W1 face is
responsible for DNA binding [28]. In WH proteins, the H3
helix typically lies in the major groove and makes most of
the sequence-speciﬁc contacts with nucleic acids via a
number of hydrogen bonds and hydrophobic interactions
[10]. A superposition of the N-terminal domain of Rv2827c
with structures of protein-DNA complexes such as heat
shock transcription factor (PDB code 3HTS, [46]), serum
response factor (PDB code 1K6O, [51]), transcription factor
Pu.1 (PDB code 1PUE, [41]), or interferon regulatory factor
(PDB code 1IF1, [25]) indicates that the sequence fragment
48-ProAspSerAlaIleArgGluLeuArgArgIle-58 of Rv2827c
(a3) might be responsible for the interaction with DNA. The
presence of three Arg residues in the fragment further sup-
ports this hypothesis. An analysis of the electrostatic surface
potential (Fig. 4) reveals that one side of the protein is
negatively charged and includes a metal binding site
whereas the other side shows a continuous path of positive
potential extending along the whole molecule including the
Fig. 2 The deﬁnition of
structural domains of Rv2827c
using various computational
approaches
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123potential nucleic acid binding motif in the N-terminal
domain containing the helix a3. The second and third helices
of the WH unit form a HTH variant motif containing a
longer turn than the corresponding turn in canonical HTH
proteins [10]. The HTH motif has been found in many DNA
binding proteins that regulate gene expression and also in
proteins involved in DNA repair and replication, as well as
in RNA metabolism. It consists of two helices connected by
the turn, in which Gly is usually found in its ﬁrst [10]o r
second position [37]. The length of the turn connecting two
helices of the typical HTH motif is 3 or 4 residues. In
Rv2827c the HTH motif is built up of 27 residues, charac-
terized by helices a2 (Lys32-Ala42) and a3( P r o 4 8 - I l e 5 8 )
linked by a ﬁve-residue turn which contains two Gly resi-
dues (Gly43 and Gly45). Although the turn contains two
extra residues, its conformation resembles more closely the
typical HTH motif than that found in WH proteins. In
contrast, the angle between the two helices is approximately
100  although for a typical HTH motif it is usually about
120  [11]. For WH proteins, the angle between the two
helices ranges from 100  in biotin operator repressor protein
BirA [81]t o1 5 0   in transcription factor DP2 [85].
The C-terminal domain constitutes a novel fold
A structural search using the entire C-terminal domain did
not yield any similarity hits to other known structures. Only
whensmallersegmentswereused,similarmotifswerefound
in other protein structures. For the fragment Ile80-Pro145,
the highest scoring structure identiﬁed by SSM is the
Table 5 Structures related to the N-terminal domain of Mtb Rv2827c identiﬁed by secondary structure matching [42]
Rank Q-
score
Z-
score
RMSD [A ˚ ´]N aligned Fragment
aligned
Identity [%] PDB:chain Function Reference
n.a. 1.00 8.8 0.00 61 Thr13-Ile73 100 1ZEL:A Probably DNA binding This work
1 0.55 3.5 2.03 57 Glu3-Lys66 12 1WQ2:B Reductase [18]
2 0.54 4.2 1.93 52 Asp112-Gly169 12 2HEO:D DNA binding [49]
3 0.53 3.9 1.97 54 Asp138-Ala198 19 1QBJ:B RNA binding [72]
4 0.51 4.8 2.38 59 Val207-Thr267 12 1Z1D:A Replication [3]
5 0.46 3.4 2.49 54 Ser14-Thr73 21 1OYI:A RNA binding [39]
6 0.44 3.9 2.24 54 Glu12-Asn72 17 1SFU:A DNA binding [32]
7 0.44 3.5 2.38 55 Lys483-Lys556 11 1W1W:G DNA binding [33]
8 0.43 4.3 2.23 54 Ser4-Leu70 11 2JT1:A Transcription Aramini et al. unpubl. data
9 0.43 2.9 2.65 59 Thr27-Ala96 10 1HST:A Chromosomal protein [68]
10 0.42 3.1 2.29 58 Asp9-Asn71 6 1P6R:A Penicillinase repressor [50]
The list is sorted by the Q-score. Other quality indicators of a structural alignment are also given as the Z-score, the r.m.s.d. value between the
aligned stretches, the number of aligned residues and the percent amino acid sequence identity
Fig. 3 Stereo view of the superposition of the winged helix domain
of Rv2827c (fragment Thr13-Ile73, in red) with the globular domain
of histone H5 (PDB code 1HST, [68], fragment Thr27-Ala96, in
green), the viral Zalpha domain (PDB code 1SFU, [32], fragment
Glu12-Asn72, in blue), and Z-DNA binding protein 1 (PDB code
2HEO, [49], fragment Asp112-Gly169, in yellow). The ﬁgure was
prepared with the program PYMOL (www.pymol.org)
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123structure of the putative minimal nucleotidyltransferase
(NMR structure, PDB code 1WOT, Suzuki et al. unpubl.
data).ForthefragmentSer212-Arg251, whichistheparallel
three-helix bundle (a12, a13, and a14) several other struc-
tures were identiﬁed. Among them are the hypothetical
protein ST1625p from the hyperthermophilic archaeon
Sulfolobus tokodaii (PDB code 1WY6, [83]) and human
PEX5 (PDB code 1FCH, [30]). For the fragment Leu175-
Ala295, no other similar structure could be identiﬁed, indi-
cating that this fragment is unique, despite a sequence
identity of 29% to 6-hydroxymethyl-7,8-dihydropterin
pyrophosphokinase from E. coli (PDB code 1RU1, [8]).
The sodium binding site
The C-terminal domain of Rv2827c subunit harbors a
metal binding site formed by two Asp residues, one water
molecule and the side chain of an Arg residue. In the
reﬁned structure the metal ion has been identiﬁed as Na
?,
although both Na
? and K
? were present in the crystalli-
zation solution at concentrations of 1.0 M and 0.075 M,
respectively. The coordination number for the metal ion is
six with the Me…X distances in chains A and B being 2.25
and 2.28 A ˚ (Asp206-OD1), 2.55 and 2.44 A ˚ (Asp206-O),
2.26 and 2.38 A ˚ (Asp210-OD1), 2.46 and 2.54 A ˚ (Asp210-
OD2), 2.43, 2.27 A ˚ (water-O) and 3.10 and 3.28 A ˚
(Arg164-CZ). If the two carboxylate oxygens of Asp210
are counted as two ligands, the coordination geometry of
the metal ion constitutes a distorted octahedron. This,
together with the observed distances favors the presence of
Na
? over K
? [35]. An analysis of the bond-valence
parameters [12–14, 53] conﬁrms this observation. The
values of this parameter for Na
? are 1.16 and 1.31 (for the
site in chains A and B, respectively), which is close to the
expected value for this ion, while for K
? the values are
2.82 and 2.99. An usual feature of this site is that the
guanidinium side chain of Arg164 is placed such that is
Fig. 4 Surface presentation of M. tuberculosis Rv2827c, showing the
electrostatic potential. The ﬁgure was prepared using PYMOL
(www.pymol.org). The distribution of the electrostatic surface
potential indicates that one side of the protein is negatively charged
(red); this area includes the metal binding site. On the opposite side
there is a continuous positively charged patch extending for the entire
length of the molecule (blue), which includes the potential nucleic
acid binding motif in the N-terminal domain containing the a3 helix
Fig. 5 Stereo view of the metal
binding site in the C-terminal
domain of Rv2827c. The
unusual coordination of the
metal ion by an Arg residue via
a p-interaction is shown in
green. The distances between
the metal ion and the ligands are
given in A ˚
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123makes a p-contact with the metal ion while its hydrogen
atoms are involved in interactions with Leu110-O, Asp206-
O and a water molecule (Fig. 5). In the crystal structure of
the GABA(A) repressor-associated protein (PDB code
1KJT, [5]) Na
? is also coordinated by an Arg side chain
but in this case, the NH1-atom of Arg65 is directed toward
the Na
? so that a p-contact as the one found in Rv2827c
can not form. The role of the metal binding site in Rv2827c
is unknown. It is located on the opposite side of the protein
with respect to the potential nucleic acid binding site, in the
region with mostly negatively charged character. It may
thus just serve the purpose of structurally stabilizing the
protein.
DNA binding properties of Rv2827c
Initial hints toward DNA binding properties of Rv2827c
were obtained from experiments, which revealed that in
the presence of DNA Rv2827c becomes more stable in
solution and remains soluble even at low imidazole con-
centrations. Without DNA, Rv2827c is only stable at high
concentrations of imidazole [38]. Of the four randomly
chosen DNA sequences tried (Table 3), three were able to
stabilize Rv2827c. Only the 26-bp fragment taken from the
DNA complex of interferon regulatory factor 1 (PDB code
1IF1, [25]) did not stabilize Rv2827c, which precipitated
during the dialysis. Neither the sequences nor the G ? C
content of the nucleotides used in the experiment provide
an explanation for this phenomenon. A DNA binding test
using the PCR-assisted binding site selection method [56]
clearly demonstrated that Rv2827c possesses dsDNA
binding capability. However, the DNA sequences derived
from the 17 randomly picked clones did not reveal any
sequence preference (Table 4). Based on this experiment
we can only conclude that Rv2827c binds DNA in a non-
speciﬁc manner.
Model of the complex of Rv2827c with DNA
A superposition of the N-terminal domain of Rv2827c and
the WH domain of the interferon regulatory factor 3 (IRF-
3, PDB code 1T2 K, [64]) complexed with a 31-mer DNA
fragment results in the model shown in Fig. 6a. The DNA
fragment ﬁts well to the positively charged N-terminal
domain, and it continues alongside Rv2827c next to the
positively charged side of the C-terminal domain (Fig. 4).
If the C-terminal domain is slightly rotated relative to the
N-terminal domain by adjusting the orientation of the C-
terminal domain, then ﬁt can be markedly improved
(Fig. 6b). An ASA calculation on the Rv2827c/DNA-
complex model reveals that DNA binding buries 1,330 A ˚ 2
of surface area of Rv2827c, which amounts to 8.7% of its
total surface. This lends further support to the hypothesis
that Rv2827c is a DNA binding protein. In an anomalous
difference Fourier map calculated based on the Br peak
data set, 23 bromide binding sites can be identiﬁed. All but
one bromide binding sites are conserved and occur in both
independent molecules in the asymmetric unit. Four out of
eleven sites in chain A and four out of twelve sites in chain
B are located in the protein-DNA interface. This indicates a
clear preference for negatively charged bromide ions to
bind to the potential positively charged DNA binding
surface further supporting the DNA binding hypothesis and
the model of the Rv2827c/DNA complex.
Conclusions
In this article we present the three-dimensional structure of
the hypothetical protein Rv2827c from Mtb determined at
1.93 A ˚ resolution using the three-wavelength anomalous
diffraction method. Rv2827c consists of two structural
domains. The structure of the C-terminal domain of
Rv2827c constitutes a novel fold whereas the structure of
the N-terminal domain of Rv2827c exhibits a winged helix
topology. A structural Na
? binding site was identiﬁed with
an unusual coordination of the metal ion by a guanidinium
side chain of Arg. It could also be shown that the presence
of oligonucleotides can stabilize Rv2827c and prevent
spontaneous precipitation in imidazole-free buffer.
Furthermore, by PCR-assisted binding site selection it was
demonstrated that Rv2827c indeed binds dsDNA. The
analysis of the charge of the accessible surface area of
Rv2827c suggests that both domains are involved in the
interaction with DNA or RNA.
Fig. 6 Interaction of Rv2827c with B-DNA. In a the structure of
Rv2827c as determined is shown, whereas in b the model of Rv2827c
which was obtained after adjusting the orientation of the C-terminal
domain
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